Cantourage
Philip Schetter currently holds the position of CEO at Cantourage Group SE and has been serving as Managing Director of Cantourage GmbH since April 2021. Prior experience includes multiple leadership roles at Aurora Europe GmbH from August 2018 to April 2021, managing operations and special projects. Philip also held a position as Managing Director at Aurora Deutschland GmbH for a year. Prior to that, work at undconsorten LLP spanned from 2010 to 2018 in various managerial capacities. Early career experiences include summer associate roles at Goldman Sachs and Deutsche Bank, as well as an internship at Infineon Technologies. Philip completed a Diplom-Ingenieur in Wirtschaftsingenieurwesen at the Karlsruhe Institute of Technology and has academic experience at the University of Sydney.
This person is not in any teams
Cantourage
Cantourage is a leading European medical cannabis provider. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffman. Cantourage empowers producers from around the globe to introduce their products to the growing and profitable European market faster and more cost-effectively – while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, dronabinol and pharmaceutical-grade cannabidiol.